HEXACOSANOIC ACID

HEXACOSANOIC ACID is a lipid of Fatty Acyls (FA) class. Hexacosanoic acid is associated with abnormalities such as Adrenoleukodystrophy, Adrenal gland hypofunction and Chronic liver disease NOS. The involved functions are known as peroxisome targeting signal-2 binding activity, Oxidation, Demyelination, Mutation and Biosynthetic Pathways. Hexacosanoic acid often locates in peroxisome, Body tissue, Mitochondria, Membrane and Cytoplasm. The associated genes with HEXACOSANOIC ACID are ABCD1 gene, TRAM1 gene, GPX1 gene, SOD1 gene and SOD2 gene. The related lipids are Fatty Acids, Stearic acid, inositolphosphorylceramide, Very long chain fatty acid and Nonesterified Fatty Acids. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of HEXACOSANOIC ACID, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with HEXACOSANOIC ACID?

HEXACOSANOIC ACID is suspected in Adrenoleukodystrophy, Adrenal gland hypofunction, Chronic liver disease NOS and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with HEXACOSANOIC ACID

MeSH term MeSH ID Detail
Body Weight D001835 333 associated lipids
Liver Diseases D008107 31 associated lipids
Kidney Diseases D007674 29 associated lipids
Leukemia P388 D007941 43 associated lipids
Metabolism, Inborn Errors D008661 46 associated lipids
Adrenoleukodystrophy D000326 29 associated lipids
Diffuse Cerebral Sclerosis of Schilder D002549 8 associated lipids
Arteriosclerosis D001161 86 associated lipids
Metabolic Diseases D008659 12 associated lipids
Adrenocortical Hyperfunction D000308 3 associated lipids
Per page 10 20 | Total 17

PubChem Associated disorders and diseases

What pathways are associated with HEXACOSANOIC ACID

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with HEXACOSANOIC ACID?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with HEXACOSANOIC ACID?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with HEXACOSANOIC ACID?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with HEXACOSANOIC ACID?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with HEXACOSANOIC ACID?

Knock-out

Knock-out are used in the study 'A key role for the peroxisomal ABCD2 transporter in fatty acid homeostasis.' (Fourcade S et al., 2009).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with HEXACOSANOIC ACID

Download all related citations
Per page 10 20 50 100 | Total 136
Authors Title Published Journal PubMed Link
Deng F et al. New flavonoids and other constituents from Lespedeza cuneata. J Asian Nat Prod Res pmid:17943561
pmid:
Kawamura N et al. High concentration of hexacosanoate in cultured skin fibroblast lipids from adrenoleukodystrophy patients. 1978 Biochem. Biophys. Res. Commun. pmid:666828
Moser HW et al. Adrenoleukodystrophy: elevated C26 fatty acid in cultured skin fibroblasts. 1980 Ann. Neurol. pmid:7436359
Kishimoto Y et al. Adrenoleukodystrophy: evidence that abnormal very long chain fatty acids of brain cholesterol esters are of exogenous origin. 1980 Biochem. Biophys. Res. Commun. pmid:7437052
Gunasekera SP et al. Constituents of Nealchornea yapurenis (Euophorbiaceae). 1980 Mar-Apr J. Nat. Prod. pmid:7381509
Moser HW et al. Adrenoleukodystrophy: increased plasma content of saturated very long chain fatty acids. 1981 Neurology pmid:7202134
Tsuji S et al. Increased synthesis of hexacosanoic acid (C23:0) by cultured skin fibroblasts from patients with adrenoleukodystrophy (ALD) and adrenomyeloneuropathy (AMN). 1981 J. Biochem. pmid:7309718
Molzer B et al. Fatty acid patterns in brain, fibroblast, leukocyte and body fluid lipids in adrenoleukodystrophy. 1981 Acta Neuropathol Suppl pmid:6939237
Moser HW et al. The prenatal diagnosis of adrenoleukodystrophy. Demonstration of increased hexacosanoic acid levels in cultured amniocytes and fetal adrenal gland. 1982 Pediatr. Res. pmid:7063272
Bakkeren JA et al. Serum very long chain fatty acid pattern in Zellweger syndrome. 1984 Clin. Chim. Acta pmid:6723067
Pretorius PJ et al. Biochemical evidence for clinically diagnosed adrenoleucodystrophy in two brothers. 1984 S. Afr. Med. J. pmid:6729621
Moser AE et al. The cerebrohepatorenal (Zellweger) syndrome. Increased levels and impaired degradation of very-long-chain fatty acids and their use in prenatal diagnosis. 1984 N. Engl. J. Med. pmid:6709009
Van Duyn MA et al. The design of a diet restricted in saturated very long-chain fatty acids: therapeutic application in adrenoleukodystrophy. 1984 Am. J. Clin. Nutr. pmid:6465061
Moser HW et al. Adrenoleukodystrophy: survey of 303 cases: biochemistry, diagnosis, and therapy. 1984 Ann. Neurol. pmid:6524872
Poulos A and Sharp P Plasma and skin fibroblast C26 fatty acids in infantile Refsum's disease. 1984 Neurology pmid:6209596
Tsuji S et al. Metabolism of [17,18-3H2]hexacosanoic acid and [15,16-3H2]lignoceric acid in cultured skin fibroblasts from patients with adrenoleukodystrophy (ALD) and adrenomyeloneuropathy (AMN). 1985 J. Neurol. Sci. pmid:4087029
Turpin JC et al. [Adult disclosure of a case of familial adrenoleukodystrophy]. 1985 Rev. Neurol. (Paris) pmid:2990005
Boué J et al. First trimester prenatal diagnosis of adrenoleukodystrophy by determination of very long chain fatty acid levels and by linkage analysis to a DNA probe. 1985 Hum. Genet. pmid:3856557
Govaerts L et al. Disturbed very long chain (C24-C26) fatty acid pattern in fibroblasts of patients with Zellweger's syndrome. 1985 J. Inherit. Metab. Dis. pmid:3921760
Krause KH et al. [EMG and evoked potentials in adrenomyeloneuropathy]. 1985 EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb pmid:3930208
Sakai T et al. Very long-chain fatty acids in neutral lipids and glycerophospholipids of adrenoleukodystrophy-cultured skin fibroblasts. 1985 J. Neurol. Sci. pmid:4087027
Lambert MA et al. Analysis of mycolic acid cleavage products and cellular fatty acids of Mycobacterium species by capillary gas chromatography. 1986 J. Clin. Microbiol. pmid:3084554
Rizzo WB et al. Adrenoleukodystrophy: oleic acid lowers fibroblast saturated C22-26 fatty acids. 1986 Neurology pmid:3951702
Wanders RJ et al. Peroxisomal fatty acid beta-oxidation in relation to the accumulation of very long chain fatty acids in cultured skin fibroblasts from patients with Zellweger syndrome and other peroxisomal disorders. 1987 J. Clin. Invest. pmid:3680527
Tanaka K et al. Electronmicroscopic study on biopsied rectal mucosa in adrenoleukodystrophy. 1987 Neurology pmid:3587618
Watkins PA et al. Adrenoleukodystrophy: biochemical procedures in diagnosis, prevention and treatment. 1987 J. Inherit. Metab. Dis. pmid:3119941
Rizzo WB et al. Adrenoleukodystrophy: dietary oleic acid lowers hexacosanoate levels. 1987 Ann. Neurol. pmid:3037987
Sereni C et al. Adult adrenoleukodystrophy: a sporadic case? 1987 J. Neurol. Sci. pmid:3681326
Moser HW Adrenoleukodystrophy: from bedside to molecular biology. 1987 J. Child Neurol. pmid:3598142
Wanders RJ et al. Prenatal diagnosis of Zellweger syndrome by measurement of very long chain fatty acid (C26:0) beta-oxidation in cultured chorionic villous fibroblasts: implications for early diagnosis of other peroxisomal disorders. 1987 Clin. Chim. Acta pmid:3652452
Moser AB et al. A new dietary therapy for adrenoleukodystrophy: biochemical and preliminary clinical results in 36 patients. 1987 Ann. Neurol. pmid:2440378
Singh H et al. Beta-oxidation of very-long-chain fatty acids and their coenzyme A derivatives by human skin fibroblasts. 1987 Arch. Biochem. Biophys. pmid:2437859
Wanders RJ et al. Impaired ability of peroxisomes to activate very-long-chain fatty acids in X-linked adrenoleukodystrophy. 1988 Lancet pmid:2899227
Whitcomb RW et al. Effects of long-chain, saturated fatty acids on membrane microviscosity and adrenocorticotropin responsiveness of human adrenocortical cells in vitro. 1988 J. Clin. Invest. pmid:2891726
Wanders RJ et al. Direct demonstration that the deficient oxidation of very long chain fatty acids in X-linked adrenoleukodystrophy is due to an impaired ability of peroxisomes to activate very long chain fatty acids. 1988 Biochem. Biophys. Res. Commun. pmid:3382393
Boggs JM et al. Influence of structural modifications on the phase behavior of semi-synthetic cerebroside sulfate. 1988 Biochim. Biophys. Acta pmid:3349071
Sano M et al. [Two adult cases of adrenoleukodystrophy with clinical features of striatonigral degeneration--a probable variant of adrenoleukodystrophy]. 1988 Rinsho Shinkeigaku pmid:3246111
Kawahara K et al. Hexacosanoate contents in Japanese common foods. 1988 J. Nutr. Sci. Vitaminol. pmid:3244051
Harris HM et al. Phytanic acid, pristanic acid, and very-long-chain fatty acid methyl esters measured simultaneously by capillary gas chromatography. 1989 Clin. Chem. pmid:2702761
Rizzo WB et al. Dietary erucic acid therapy for X-linked adrenoleukodystrophy. 1989 Neurology pmid:2682348
Wanders RJ et al. Infantile phytanic acid storage disease, a disorder of peroxisome biogenesis: a case report. 1990 J. Neurol. Sci. pmid:1700075
Kyllerman M et al. Central nervous system malformations and white matter changes in pseudo-neonatal adrenoleukodystrophy. 1990 Neuropediatrics pmid:2290480
Sadeghi-Nejad A and Senior B Adrenomyeloneuropathy presenting as Addison's disease in childhood. 1990 N. Engl. J. Med. pmid:2294415
Jakobs BS and Wanders RJ Conclusive evidence that very-long-chain fatty acids are oxidized exclusively in peroxisomes in human skin fibroblasts. 1991 Biochem. Biophys. Res. Commun. pmid:1872864
Lageweg W et al. Oxidation of very-long-chain fatty acids in rat brain: cerotic acid is beta-oxidized exclusively in rat brain peroxisomes. 1991 Biochim. Biophys. Acta pmid:1911873
Caruso U et al. Determination of very-long-chain fatty acids in plasma by a simplified gas chromatographic-mass spectrometric procedure. 1991 J. Chromatogr. pmid:2026688
Lageweg W et al. Long-chain-acyl-CoA synthetase and very-long-chain-acyl-CoA synthetase activities in peroxisomes and microsomes from rat liver. An enzymological study. 1991 Eur. J. Biochem. pmid:2007410
Van den Branden C et al. Altered adrenocortical response under the influence of experimentally increased serum very long chain fatty acids in rats. 1993 Pathol. Res. Pract. pmid:8397390
Aveldaño MI and Donnari D Plasma phospholipid fatty acids in X-linked adrenoleukodystrophy. 1996 Clin. Chem. pmid:8598113
Christensen E et al. A new peroxisomal beta-oxidation disorder in twin neonates: defective oxidation of both cerotic and pristanic acids. 1997 J. Inherit. Metab. Dis. pmid:9323560
Di Biase A et al. Effects of exogenous hexacosanoic acid on biochemical myelin composition in weaning and post-weaning rats. 1997 Neurochem. Res. pmid:9051669
Wen J et al. [Studies on the chemical constituent of Ephedra likiangensis]. 1997 Zhong Yao Cai pmid:12572520
Miwa A et al. Very long-chain fatty acid pattern in crush syndrome patients in the Kobe earthquake. 1997 Clin. Chim. Acta pmid:9074810
Miyajima H et al. Increased very long-chain fatty acids in erythrocyte membranes of patients with aceruloplasminemia. 1998 Neurology pmid:9443469
Mdluli K et al. Inhibition of a Mycobacterium tuberculosis beta-ketoacyl ACP synthase by isoniazid. 1998 Science pmid:9616124
Petroni A et al. Testosterone metabolites in patients reduce the levels of very long chain fatty acids accumulated in X-adrenoleukodystrophic fibroblasts. 2000 Neurosci. Lett. pmid:10904139
Antoku Y et al. Correlations of elevated levels of hexacosanoate in erythrocyte membranes with risk factors for atherosclerosis. 2000 Atherosclerosis pmid:11058712
Pai GS et al. Lovastatin therapy for X-linked adrenoleukodystrophy: clinical and biochemical observations on 12 patients. 2000 Mol. Genet. Metab. pmid:10870849
Tomosaka H et al. Lupeol esters from the twig bark of Japanese pear (Pyrus serotina Rehd.) cv. Shinko. 2001 Biosci. Biotechnol. Biochem. pmid:11440139
Tao ZY et al. [Studies on the chemical constituents of Zanthoxylum dimorphophyllum Hemsl. var spinifolium Rhed. et Wils]. 2001 Yao Xue Xue Bao pmid:12585082
Lii JR et al. [Lipid compounds from Echinacea purpurea]. 2002 Zhongguo Zhong Yao Za Zhi pmid:12774354
Rudenskaia GE et al. [Clinical heterogeneity of X-linked adrenoleukodystrophy ]. 2002 Zh Nevrol Psikhiatr Im S S Korsakova pmid:12497991
Singh B and Singh S Antimicrobial activity of terpenoids from Trichodesma amplexicaule Roth. 2003 Phytother Res pmid:12916085
Chen JH et al. [Clinical evaluation of 546 tetracycline-stained teeth treated with Cerinate laminate veneers]. 2003 Zhonghua Kou Qiang Yi Xue Za Zhi pmid:12887798
Cheng J et al. [Studies on the constituents from the stems of Spatholobus suberectus]. 2003 Zhongguo Zhong Yao Za Zhi pmid:15617498
Zhang C and Fang YX [Studies on the chemical constituents of Chinese herb Melastoma dodecandrum]. 2003 Zhongguo Zhong Yao Za Zhi pmid:15139128
Vargas CR et al. Evidence that oxidative stress is increased in patients with X-linked adrenoleukodystrophy. 2004 Biochim. Biophys. Acta pmid:14732478
Bojesen IN Direct determination of unbound lipophilic ligands in aqueous solutions. 2004 Biol Proced Online pmid:19565308
Nagy K et al. An HPLC-MS approach for analysis of very long chain fatty acids and other apolar compounds on octadecyl-silica phase using partly miscible solvents. 2004 Anal. Chem. pmid:15053654
Di Biase A et al. Free radical release in C6 glial cells enriched in hexacosanoic acid: implication for X-linked adrenoleukodystrophy pathogenesis. 2004 Neurochem. Int. pmid:14602084
Chen YG et al. 11-Methoxyviburtinal, a new iridoid from Valeriana jatamansi. 2005 Arch. Pharm. Res. pmid:16276973
Ramjit HG et al. A novel coaxial electrospray ionization method for characterizing hexacosanoylceramides by Fourier transform ion cyclotron resonance mass spectrometry. 2005 Rapid Commun. Mass Spectrom. pmid:15838927
Chen JH et al. Clinical evaluation of 546 tetracycline-stained teeth treated with porcelain laminate veneers. 2005 J Dent pmid:15652162
Vallée B and Riezman H Lip1p: a novel subunit of acyl-CoA ceramide synthase. 2005 EMBO J. pmid:15692566
Moser HW et al. Follow-up of 89 asymptomatic patients with adrenoleukodystrophy treated with Lorenzo's oil. 2005 Arch. Neurol. pmid:16009761
Dhaunsi GS et al. Very long chain fatty acids activate NADPH oxidase in human dermal fibroblasts. 2005 Jan-Feb Cell Biochem. Funct. pmid:15565636
Chen JH et al. [Measurement and comparison of the spectral transmittance of cerinate porcelain and human enamel]. 2006 Hua Xi Kou Qiang Yi Xue Za Zhi pmid:17334072
Deon M et al. The effect of Lorenzo's oil on oxidative stress in X-linked adrenoleukodystrophy. 2006 J. Neurol. Sci. pmid:16750542
Chen YG et al. Compounds with DNA cleaving activity from Kadsura ananosma. 2006 Pharmazie pmid:17069433
Hubbard WC et al. Combined liquid chromatography-tandem mass spectrometry as an analytical method for high throughput screening for X-linked adrenoleukodystrophy and other peroxisomal disorders: preliminary findings. 2006 Sep-Oct Mol. Genet. Metab. pmid:16828324
Qin WJ et al. [Studies on chemical constituents of Heterosmilax yunnanensis]. 2007 Zhong Yao Cai pmid:18074845
Gutierrez AL et al. Characterization of glycoinositolphosphoryl ceramide structure mutant strains of Cryptococcus neoformans. 2007 Glycobiology pmid:17369287
Ohta M et al. Novel free ceramides as components of the soldier defense gland of the Formosan subterranean termite (Coptotermes formosanus). 2007 J. Lipid Res. pmid:17164223
Meng Z et al. Rapid determination of C12-C26 non-derivatized fatty acids in human serum by fast gas chromatography. 2007 J Sep Sci pmid:17623434
Matias AC et al. Down-regulation of fatty acid synthase increases the resistance of Saccharomyces cerevisiae cells to H2O2. 2007 Free Radic. Biol. Med. pmid:17936191
Deon M et al. Induction of lipid peroxidation and decrease of antioxidant defenses in symptomatic and asymptomatic patients with X-linked adrenoleukodystrophy. 2007 Int. J. Dev. Neurosci. pmid:17928186
Di Benedetto R et al. RNAi-mediated silencing of ABCD3 gene expression in rat C6 glial cells: a model system to study PMP70 function. 2008 Neurochem. Int. pmid:18178290
Kume A et al. High levels of saturated very long-chain fatty acid (hexacosanoic acid; C26:0) in whole blood are associated with metabolic syndrome in Japanese men. 2008 Diabetes Res. Clin. Pract. pmid:18242759
Fourcade S et al. Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy. 2008 Hum. Mol. Genet. pmid:18344354
Yanagisawa N et al. Enhanced production of nitric oxide, reactive oxygen species, and pro-inflammatory cytokines in very long chain saturated fatty acid-accumulated macrophages. 2008 Lipids Health Dis pmid:19038055
Deon M et al. Hexacosanoic and docosanoic acids plasma levels in patients with cerebral childhood and asymptomatic X-linked adrenoleukodystrophy: Lorenzo's oil effect. 2008 Metab Brain Dis pmid:18026827
Chung TC et al. A simple and sensitive liquid chromatographic method for the analysis of free docosanoic, tetracosanoic and hexacosanoic acids in human plasma as fluorescent derivatives. 2008 Anal. Chim. Acta pmid:18298975
Veerapen N et al. Synthesis and biological activity of alpha-galactosyl ceramide KRN7000 and galactosyl (alpha1-->2) galactosyl ceramide. 2009 Bioorg. Med. Chem. Lett. pmid:19502056
Fourcade S et al. A key role for the peroxisomal ABCD2 transporter in fatty acid homeostasis. 2009 Am. J. Physiol. Endocrinol. Metab. pmid:18854420
Khare G et al. Dissecting the role of critical residues and substrate preference of a Fatty Acyl-CoA Synthetase (FadD13) of Mycobacterium tuberculosis. 2009 PLoS ONE pmid:20027301
Pillai BK et al. Fast diffusion of very long chain saturated fatty acids across a bilayer membrane and their rapid extraction by cyclodextrins: implications for adrenoleukodystrophy. 2009 J. Biol. Chem. pmid:19801636
Figueiras AN et al. Epicuticular lipids induce aggregation in Chagas disease vectors. 2009 Parasit Vectors pmid:19173716
Brites P et al. Plasmalogens participate in very-long-chain fatty acid-induced pathology. 2009 Brain pmid:19022859
Okahashi A et al. Concentrations of very long-chain fatty acid in whole blood are associated with cardiovascular risk factors in children. 2009 Clin. Chim. Acta pmid:19135040